Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |